VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
anti- TNF-a
Preclinical
Small molecule
C
Chang Gung Memorial Hospital
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Adverse Drug Reactions
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Adverse Drug Reactions
Preclinical
Completed
Clinical
Trials by Indication
[1]
Adverse Drug Reactions
1 trial
Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions
Completed
·
—
·
N/A
·
NCT01276314
·
135 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for anti- TNF-a. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
anti- TNF-a compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for anti- TNF-a. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Chang Gung Memorial Hospital company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
C
Chang Gung Memorial Hospital
Related News